Test Overview
Test Methodology

Chemiluminescent Immunoassay (CLIA)

Test Usage

To follow patients with neoplasm and to evaluate the effect of the antineoplastic therapy, particularly in pancreatic and colorectal carcinoma.

Reference Range *

No established reference range.

* Reference ranges may change over time. Please refer to the original patient report when evaluating results.

Test Limitations

CEA levels are elevated in smokers, former smokers, patients with inflammatory bowel diseases, and patients with Non colorectal or pancreatic neoplasms.

Test Details
Days Set Up
Daily, 24 hours
Analytic Time

8 hours

Soft Order Code
CEAF
MiChart Code
CEAF
Laboratory
Chemical Pathology
Section
Automation
Specimen Requirements
Collection Instructions

Collect pancreatic cyst fluid in SST or red top tube, or sterile container with no preservative. Refrigerate. Pancreatic cyst fluid must be of liquid consistency for analysis.

Contraindications
This test should not be used as a screening test for carcinoma.
Normal Volume
1.0 mL of pancreatic cyst fluid
Minimum Volume
0.5 mL of pancreatic cyst fluid
Additional Information

Tested by chemiluminescent immunoassay manufactured by Siemens Healthineers, performed on Atellica IM system.

Billing
CPT Code
82378
Fee Code
23322
LOINC
2039-6